Cargando…
Undetectable Anti-HBs Antibodies: Need of a Booster Dose for HIV-1-Infected Individuals
HBV vaccination effectively prevents HBV transmission and the development of liver cancer. Disease progression and liver-related complications are more common in HIV-1/HBV co-infected than HBV mono-infected individuals. A considerable body of literature, which will be reviewed here, indicates that r...
Autores principales: | Bekele, Yonas, Berzofsky, Jay A., Chiodi, Francesca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703597/ https://www.ncbi.nlm.nih.gov/pubmed/34960230 http://dx.doi.org/10.3390/vaccines9121484 |
Ejemplares similares
-
The Role of CXCL13 in Antibody Responses to HIV-1 Infection and Vaccination
por: Bekele Feyissa, Yonas, et al.
Publicado: (2021) -
Protective Anti-HBs Antibodies and Response to a Booster Dose in Medical Students Vaccinated at Childhood
por: Coppeta, Luca, et al.
Publicado: (2023) -
Circulating immune complexes and mutations of HBsAg are associated with the undetectable HBsAg in anti-HBs and HBeAg positive occult hepatitis B virus infection
por: Yan, Ying, et al.
Publicado: (2022) -
Predictive factors for anti-HBs status after 1 booster dose of hepatitis B vaccine
por: Lu, I-Cheng, et al.
Publicado: (2016) -
Is There Any Opportunity to Provide an HBV Vaccine Booster Dose before Anti-Hbs Titer Vanishes?
por: Papadopoli, Rosa, et al.
Publicado: (2020)